drugset / Trial / NCT02149433

Pneumocystis Jerovici Pneumonia in Infants and Steroids

NCT02149433

Completed 78 enrolled Kamuzu University of Health Sciences
RandomizedSingle-groupTriple-blindTreatment

Summary

This is a double-blind randomized controlled trial assessing the efficacy of adjuvant corticosteroids in clinically diagnosed Pneumocystis jiroveci pneumonia in infants.

Timeline

Start
2012-05
Primary completion
2014-08
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 0.5 mg/kg Oral

Indications